These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9717815)

  • 1. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.
    Koppenhagen FJ; Küpcü Z; Wallner G; Crommelin DJ; Wagner E; Storm G; Kircheis R
    Clin Cancer Res; 1998 Aug; 4(8):1881-6. PubMed ID: 9717815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice.
    Kircheis R; Küpcü Z; Wallner G; Rössler V; Schweighoffer T; Wagner E
    Cancer Gene Ther; 2000 Jun; 7(6):870-8. PubMed ID: 10880017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
    Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
    Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
    Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma.
    Kircheis R; Küpcü Z; Wallner G; Wagner E
    Cytokines Cell Mol Ther; 1998 Jun; 4(2):95-103. PubMed ID: 9681248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on anti-tumor immunity induced by gene-modified melanoma B16 cells.
    Fang L; Wang K; Liu X; Zhang L; Zhang X; Qian L; Lu J; Qian G; Ge S
    Oncol Rep; 2008 Jun; 19(6):1589-95. PubMed ID: 18497970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
    Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
    Björkdahl O; Dohlsten M; Sjögren HO
    Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
    de Zoeten EF; Carr-Brendel V; Cohen EP
    J Immunol; 1998 Mar; 160(6):2915-22. PubMed ID: 9510195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors.
    Cao X; Chen C; Zhang W; Tao Q; Yu Y; Ye T
    Gene Ther; 1996 May; 3(5):421-6. PubMed ID: 9156803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100.
    Xia DJ; Zhang WP; Zheng S; Wang J; Pan JP; Wang Q; Zhang LH; Hamada H; Cao X
    Gene Ther; 2002 May; 9(9):592-601. PubMed ID: 11973635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effect of interleukin-2 gene-transfected tumor vaccine in combination with interleukin-6 gene-transfected tumor vaccine].
    Cao X; Zhang W; Tao Q
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):602-5, 639. PubMed ID: 8697075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine.
    Schirmacher V; Förg P; Dalemans W; Chlichlia K; Zeng Y; Fournier P; von Hoegen P
    Gene Ther; 2000 Jul; 7(13):1137-47. PubMed ID: 10918481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes as cytokine-supplement in tumor cell-based vaccines.
    van Slooten ML; Kircheis R; Koppenhagen FJ; Wagner E; Storm G
    Int J Pharm; 1999 Jun; 183(1):33-6. PubMed ID: 10361150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines.
    Akiyama Y; Watanabe M; Maruyama K; Ruscetti FW; Wiltrout RH; Yamaguchi K
    Gene Ther; 2000 Dec; 7(24):2113-21. PubMed ID: 11223993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect.
    Faham A; Altin JG
    J Immunol; 2010 Aug; 185(3):1744-54. PubMed ID: 20610649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.